Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin‐induced extracorporeal LDL precipitation (HELP)

European Journal of Clinical Investigation

Volumn 19, Issue 1, 1989, Pages 30-37

  SCHUFF WERNER P ^a   SCHUTZ E ^a   SEYDE, W C ^b   EISENHAUER, TH ^a   JANNING, G ^a   ARMSTRONG, V W ^a   SEIDEL, D ^a  

^a Department of Clinical Chemistry ^*

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Atherosclerosis; blood fluidity; erythrocyte aggregation; haemorheology; heparin induced LDL apheresis; LDL cholesterol; plasma viscosity; tissue oxygen tension

Indexed keywords

HEPARIN; LOW DENSITY LIPOPROTEIN;

ADULT; CLINICAL ARTICLE; FEMALE; FIBRINOGEN BLOOD LEVEL; HEREDITY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; MALE; PLASMA VISCOSITY; PLASMAPHERESIS; PRIORITY JOURNAL;

ADULT; BLOOD VISCOSITY; CORONARY DISEASE; ERYTHROCYTE AGGREGATION; EXTRACORPOREAL CIRCULATION; FEMALE; FIBRINOGEN; HEPARIN; HUMAN; HYPERCHOLESTEROLEMIA, FAMILIAL; LIPOPROTEINS, LDL; MALE; MIDDLE AGE; MUSCLES; OXYGEN CONSUMPTION; PRECIPITATION; RHEOLOGY; SUPPORT, NON-U.S. GOV'T;

EID: 0024563258     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1989.tb00192.x     Document Type: Article

References (51)

1. for the MRFIT Research Group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded
2. The Lipid Research Coronary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
3. Cholesterol and coronary heart disease. A new era
4. Increased plasma fibrinogen and platelet‐aggregates in type II hyperlipoproteinae‐mia
5. Familial hypercholesterolemia
6. Improved survival of patients with homozygous familial hypercholesterolemia treated with plasma exchange
7. Current status of therapeutic plasmapheresis and related techniques. Report of the AMA Panel on therapeutic plasmapheresis
8. Mortality in therapeutic haemapheresis
9. On the precipitation of serum lipoproteins by heparin
10. Ein neues Verfahren zur selektiven Messung und extrakorporalen Elimination von low density Lipoproteinen
11. A simple specific method for precipitation of low density lipoproteins
12. Selective continuous extracorporeal elimination of low‐density lipoproteins with heparin at acidic pH
13. Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system
14. Long‐term experience with the HELP system for treatment of severe familial hypercholesterolemia
15. Selective removal of apolipoprotein B‐containing serum lipoproteins from blood plasma
16. Selective removal oflow density lipoproteins by plasmapheresis in familial hypercholesterolemia
17. Fibrinogen as a risk factor for stroke and myocardial infarction
18. Fibrinogen and risk of cardiovascular disease. The Framingham Study
19. Haemostatic function and cardiovascular death: early results of a prospective study
20. Fibrin and Fibrinogen‐related antigens in patients with stable and unstable coronary artery disease
21. Der prädiktive Wert von rheologischen Parametern im Vergleich zu differenzierten Lipidparametern bei der Prävalenz der koronaren Herzerkrankung
22. Studies of plasma viscosity in primary hyperlipoproteinaemia
23. Plasma viscosity in 615 subjects. Effects of Fibrinogen, globulin, and cholesterol in normals, peripheral vascular disease, retinopathy, and melanoma
24. Effects of lipoproteins on plasma viscosity
25. The effects of fibrinogen and its plasmin degradation products on the rheology of erythrocyte suspensions
26. Rheology of human blood and hyperlipemia
27. Evaluation of a commercial kit for the determination of LDL‐cholesterol in serum based on precipitation of LDL with dextran sulfate
28. Das Kapillarschlauch‐Plasmaviskosimeter: Methodik, Qualitäts‐kontrolle und Referenzbereich
29. Das Mini‐Erythrozyten‐Aggregometer: Ein neues Gerät zur schnellen Quantifizierung des Ausmaßes der Erythrozytenaggregation
30. Microrheology and protein chemistry of pathological red cell aggregation (blood sludge) studied in vitro
31. 2‐histo‐grams
32. 2 in healthy volunteers and intensive care patients
33. Fibrinogen and low density lipoprotein in the development of cerebral atherosclerosis
34. Insoluble ‘fibrin’ in human aortic intima
35. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis
36. Correlation between fibrinogen binding to human platelets and platelet aggregability
37. Interactions of vasomotion and blood rheology in haemodynamics
38. Reduction of blood viscosity following plasma exchange
39. Improved reactive hyperemia test after plasma exchange in familial hypercholesterolemia
40. Experience with plasma‐exchange in homozygous familiar hypercholesterolaemia
41. Potential significance of plasma viscosity and haematocrit variations in myocardial ischaemia
42. Viscosity, blood flow and haematocrit in patients with paraproteinaemia
43. Increase in leg blood‐flow by normovolaemic haemodilution in intermittent claudication
44. Improvement in experimental vascular graft patency by controlled defibrinogenation
45. Therapeutic defibrinogenation in peripheral vascular disease
46. 2 synthesis by cultured porcine aortic endothelia and smooth muscle cells
47. Regression der Koronarsklerose bei familiärer Hypercholesterinämie IIa dutch spezifische LDL‐Apherese
48. Removal of low‐density lipoproteins in patients by extracorporeal immunoadsorption
49. Beneficial effects of combined cholestipolniacin therapy on coronary atherosclerosis and coronary venous bypass grafts
50. Regression of experimental atherosclerosis lesions in rhesus monkeys consuming a high saturated fat diet